Agitation in the critically ill patient: a marker of health or a plea for treatment?
Schweickert
William
W
Hall
Jesse B
JB
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D016292:Procedural Sedation; D003422:Critical Care; D016638:Critical Illness / Q000401:mortality / Q000628:therapy*; D003693:Delirium / Q000188:drug therapy / Q000401:mortality; D006220:Haloperidol / Q000627:therapeutic use*; D017052:Hospital Mortality; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000401:mortality; D012121:Respiration, Artificial; D015996:Survival Rate
D014150:Antipsychotic Agents; D007155:Immunologic Factors; D006220:Haloperidol